New Parkinson's disease enterprise partnership with Trinity College Institute of Neuroscience

We are pleased to announce an enterprise partnership with Professor Andrew Harkin, Trinity College Institute of neuroscience (TCIN) co-funded by Irish research Council (IRC) and Transpharmation Ltd. This partnership, initially supported for a four-year period, will establish a clinically relevant experimental platform to facilitate the development of new therapeutics for the treatment of Parkinson’s disease.